|
|
|
|
LEADER |
01431nam a2200277 u 4500 |
001 |
EB002001806 |
003 |
EBX01000000000000001164707 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
245 |
0 |
0 |
|a Topical nSAIDs versus opioids for acute musculoskeletal pain
|h Elektronische Ressource
|b a review of the clinical effectiveness
|c prepared by Canadian Agency for Drugs and Technologies in Health
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2017, 30 January 2017
|
300 |
|
|
|a 1 PDF file (18 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
|
653 |
|
|
|a Analgesics, Opioid / therapeutic use
|
653 |
|
|
|a Musculoskeletal Pain / drug therapy
|
653 |
|
|
|a Acute Disease
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Rapid response report: summary with critical appraisal
|
500 |
|
|
|a "CADTH Rapid Response Service."
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK442145
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The aim of this report is to review the clinical effectiveness of topical NSAIDs compared with opioids, placebo or no treatment in patients with acute musculoskeletal pain
|